NNNN
NASDAQ · Biotechnology
Anbio Biotechnology Ltd
$10.61
+0.86 (+8.82%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
-54.39%
1Y
-79.22%
YTD
-64.01%
Open$9.77
Previous Close$9.75
Day High$12.10
Day Low$9.55
52W High$54.95
52W Low$8.30
Volume—
Avg Volume50.0K
Market Cap1.40B
P/E Ratio137.52
EPS$0.23
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$29.64
Below
SMA 200
$30.05
Below
RSI (14)
49.5
Neutral
Trend
Death Cross
Bearish
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 26.18M | 36.56M | 1.84B |
| Net Income | 19.38M | 24.36M | -354,337,532 |
| Profit Margin | 74.1% | 70.4% | -19.2% |
| EBITDA | 17.47M | 23.17M | -454,323,212 |
| Free Cash Flow | — | — | -249,462,362 |
| Rev Growth | -28.4% | -28.4% | +17.6% |
| Debt/Equity | — | — | 0.51 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $784.36 | +1.59% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $219.20 | +1.43% | 35.2 | 28.41B |